Global Therapeutic Nuclear Medicines Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

    The Therapeutic Nuclear Medicines is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 13.4% during the forecast period. The research provides insights for the global Therapeutic Nuclear Medicines market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Therapeutic Nuclear Medicines industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Therapeutic Nuclear Medicines Market Segmentations:

    By Players:

    • Lantheus

    • International Isotopes

    • Curium Pharmaceuticals

    • Jubilant DraxImage

    • Q BioMed

    • China Isotope & Radiation

    • Progenics Pharmaceuticals

    • Bayer

    • Novartis AG

    • Dongcheng

    • Spectrum Pharmaceuticals

    By Types:

    • Radium-223

    • Lutetium-177

    • Iodine-131

    • Other

    By End-User:

    • Thyroid

    • Bone Metastasis

    • Lymphoma

    • Other

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Therapeutic Nuclear Medicines Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Radium-223 from 2014 to 2026

      • 1.3.2 Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Lutetium-177 from 2014 to 2026

      • 1.3.3 Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Iodine-131 from 2014 to 2026

      • 1.3.4 Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Thyroid from 2014 to 2026

      • 1.4.2 Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Bone Metastasis from 2014 to 2026

      • 1.4.3 Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Lymphoma from 2014 to 2026

      • 1.4.4 Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Therapeutic Nuclear Medicines Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Therapeutic Nuclear Medicines Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Therapeutic Nuclear Medicines by Major Types

      • 3.4.1 Therapeutic Nuclear Medicines Market Size and Growth Rate of Radium-223

      • 3.4.2 Therapeutic Nuclear Medicines Market Size and Growth Rate of Lutetium-177

      • 3.4.3 Therapeutic Nuclear Medicines Market Size and Growth Rate of Iodine-131

      • 3.4.4 Therapeutic Nuclear Medicines Market Size and Growth Rate of Other

    4 Segmentation of Therapeutic Nuclear Medicines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Therapeutic Nuclear Medicines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Therapeutic Nuclear Medicines in Thyroid

      • 4.4.2 Market Size and Growth Rate of Therapeutic Nuclear Medicines in Bone Metastasis

      • 4.4.3 Market Size and Growth Rate of Therapeutic Nuclear Medicines in Lymphoma

      • 4.4.4 Market Size and Growth Rate of Therapeutic Nuclear Medicines in Other

    5 Market Analysis by Major Regions

    • 5.1 Global Therapeutic Nuclear Medicines Production Analysis by Major Regions

    • 5.2 Global Therapeutic Nuclear Medicines Consumption Analysis by Major Regions

    • 5.3 Global Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis

    6 Product Commodity of Therapeutic Nuclear Medicines Market in Major Countries

    • 6.1 Top 5 Export Countries in Therapeutic Nuclear Medicines market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Therapeutic Nuclear Medicines market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Therapeutic Nuclear Medicines Landscape Analysis

    • 7.1 North America Therapeutic Nuclear Medicines Landscape Analysis by Major Types

    • 7.2 North America Therapeutic Nuclear Medicines Landscape Analysis by Major End-Users

    • 7.3 North America Therapeutic Nuclear Medicines Landscape Analysis by Major Countries

      • 7.3.1 United States Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 7.3.2 Canada Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 7.3.3 Mexico Therapeutic Nuclear Medicines Market Volume and Growth Rate

    8 Europe Therapeutic Nuclear Medicines Landscape Analysis

    • 8.1 Europe Therapeutic Nuclear Medicines Landscape Analysis by Major Types

    • 8.2 Europe Therapeutic Nuclear Medicines Landscape Analysis by Major End-Users

    • 8.3 Europe Therapeutic Nuclear Medicines Landscape Analysis by Major Countries

      • 8.3.1 Germany Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 8.3.2 UK Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 8.3.3 France Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 8.3.4 Italy Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 8.3.6 Spain Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 8.3.7 Belgium Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 8.3.8 Poland Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 8.3.9 Russia Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 8.3.10 Turkey Therapeutic Nuclear Medicines Market Volume and Growth Rate

    9 Asia Pacific Therapeutic Nuclear Medicines Landscape Analysis

    • 9.1 Asia Pacific Therapeutic Nuclear Medicines Landscape Analysis by Major Types

    • 9.2 Asia Pacific Therapeutic Nuclear Medicines Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Therapeutic Nuclear Medicines Landscape Analysis by Major Countries

      • 9.3.1 China Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 9.3.2 Japan Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 9.3.4 India Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 9.3.6 South Korea Therapeutic Nuclear Medicines Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Therapeutic Nuclear Medicines Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Therapeutic Nuclear Medicines Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Therapeutic Nuclear Medicines Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Therapeutic Nuclear Medicines Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 10.3.2 Brazil Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 10.3.3 Nigeria Therapeutic Nuclear Medicines Market Volume and Growth Rate

      • 10.3.4 South Africa Therapeutic Nuclear Medicines Market Volume and Growth Rate 

      • 10.3.5 Argentina Therapeutic Nuclear Medicines Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Lantheus

      • 11.1.1 Lantheus Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 International Isotopes

      • 11.2.1 International Isotopes Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Curium Pharmaceuticals

      • 11.3.1 Curium Pharmaceuticals Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Jubilant DraxImage

      • 11.4.1 Jubilant DraxImage Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Q BioMed

      • 11.5.1 Q BioMed Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 China Isotope & Radiation

      • 11.6.1 China Isotope & Radiation Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Progenics Pharmaceuticals

      • 11.7.1 Progenics Pharmaceuticals Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Bayer

      • 11.8.1 Bayer Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Novartis AG

      • 11.9.1 Novartis AG Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Dongcheng

      • 11.10.1 Dongcheng Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Spectrum Pharmaceuticals

      • 11.11.1 Spectrum Pharmaceuticals Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 113 Figures and 167 Tables)

    • Figure Product Picture

    • Figure Therapeutic Nuclear Medicines Market Size and Growth Rate of Radium-223 from 2014 to 2026

    • Figure Therapeutic Nuclear Medicines Market Size and Growth Rate of Lutetium-177 from 2014 to 2026

    • Figure Therapeutic Nuclear Medicines Market Size and Growth Rate of Iodine-131 from 2014 to 2026

    • Figure Therapeutic Nuclear Medicines Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Thyroid from 2014 to 2026

    • Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Bone Metastasis from 2014 to 2026

    • Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Lymphoma from 2014 to 2026

    • Figure Global Therapeutic Nuclear Medicines Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Therapeutic Nuclear Medicines Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Therapeutic Nuclear Medicines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Therapeutic Nuclear Medicines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Therapeutic Nuclear Medicines by Different Types from 2014 to 2026

    • Table Consumption Share of Therapeutic Nuclear Medicines by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Radium-223

    • Figure Market Size and Growth Rate of Lutetium-177

    • Figure Market Size and Growth Rate of Iodine-131

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Therapeutic Nuclear Medicines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Therapeutic Nuclear Medicines by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Thyroid

    • Figure Market Size and Growth Rate of Bone Metastasis

    • Figure Market Size and Growth Rate of Lymphoma

    • Figure Market Size and Growth Rate of Other

    • Table Global Therapeutic Nuclear Medicines Production by Major Regions

    • Table Global Therapeutic Nuclear Medicines Production Share by Major Regions

    • Figure Global Therapeutic Nuclear Medicines Production Share by Major Regions in 2014

    • Figure Global Therapeutic Nuclear Medicines Production Share by Major Regions in 2018

    • Figure Global Therapeutic Nuclear Medicines Production Share by Major Regions in 2026

    • Table Global Therapeutic Nuclear Medicines Consumption by Major Regions

    • Table Global Therapeutic Nuclear Medicines Consumption Share by Major Regions

    • Figure Global Therapeutic Nuclear Medicines Consumption Share by Major Regions in 2014

    • Figure Global Therapeutic Nuclear Medicines Consumption Share by Major Regions in 2018

    • Figure Global Therapeutic Nuclear Medicines Consumption Share by Major Regions in 2026

    • Table North America Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table Europe Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Therapeutic Nuclear Medicines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Therapeutic Nuclear Medicines market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Therapeutic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table North America Therapeutic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Figure North America Therapeutic Nuclear Medicines Consumption Share by Types in 2014

    • Figure North America Therapeutic Nuclear Medicines Consumption Share by Types in 2018

    • Figure North America Therapeutic Nuclear Medicines Consumption Share by Types in 2026

    • Table North America Therapeutic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table North America Therapeutic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Figure North America Therapeutic Nuclear Medicines Consumption Share by End-Users in 2014

    • Figure North America Therapeutic Nuclear Medicines Consumption Share by End-Users in 2018

    • Figure North America Therapeutic Nuclear Medicines Consumption Share by End-Users in 2026

    • Table North America Therapeutic Nuclear Medicines Consumption by Major Countries from 2014 to 2026

    • Table North America Therapeutic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2014

    • Figure North America Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2018

    • Figure North America Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2026

    • Figure United States Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Therapeutic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table Europe Therapeutic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Figure Europe Therapeutic Nuclear Medicines Consumption Share by Types in 2014

    • Figure Europe Therapeutic Nuclear Medicines Consumption Share by Types in 2018

    • Figure Europe Therapeutic Nuclear Medicines Consumption Share by Types in 2026

    • Table Europe Therapeutic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table Europe Therapeutic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Therapeutic Nuclear Medicines Consumption Share by End-Users in 2014

    • Figure Europe Therapeutic Nuclear Medicines Consumption Share by End-Users in 2018

    • Figure Europe Therapeutic Nuclear Medicines Consumption Share by End-Users in 2026

    • Table Europe Therapeutic Nuclear Medicines Consumption by Major Countries from 2014 to 2026

    • Table Europe Therapeutic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2014

    • Figure Europe Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2018

    • Figure Europe Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2026

    • Figure Germany Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure France Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Therapeutic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Types in 2014

    • Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Types in 2018

    • Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Types in 2026

    • Table Asia Pacific Therapeutic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Therapeutic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by End-Users in 2014

    • Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by End-Users in 2018

    • Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by End-Users in 2026

    • Table Asia Pacific Therapeutic Nuclear Medicines Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2026

    • Figure China Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandTherapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure India Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Therapeutic Nuclear Medicines Consumption Share by Major Countries in 2026

    • Figure GCC Countries Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Therapeutic Nuclear Medicines Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Lantheus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus

    • Figure Sales and Growth Rate Analysis of Lantheus

    • Figure Revenue and Market Share Analysis of Lantheus

    • Table Product and Service Introduction of Lantheus

    • Table Company Profile and Development Status of International Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of International Isotopes

    • Figure Sales and Growth Rate Analysis of International Isotopes

    • Figure Revenue and Market Share Analysis of International Isotopes

    • Table Product and Service Introduction of International Isotopes

    • Table Company Profile and Development Status of Curium Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Curium Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Curium Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Curium Pharmaceuticals

    • Table Product and Service Introduction of Curium Pharmaceuticals

    • Table Company Profile and Development Status of Jubilant DraxImage

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant DraxImage

    • Figure Sales and Growth Rate Analysis of Jubilant DraxImage

    • Figure Revenue and Market Share Analysis of Jubilant DraxImage

    • Table Product and Service Introduction of Jubilant DraxImage

    • Table Company Profile and Development Status of Q BioMed

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Q BioMed

    • Figure Sales and Growth Rate Analysis of Q BioMed

    • Figure Revenue and Market Share Analysis of Q BioMed

    • Table Product and Service Introduction of Q BioMed

    • Table Company Profile and Development Status of China Isotope & Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope & Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope & Radiation

    • Figure Revenue and Market Share Analysis of China Isotope & Radiation

    • Table Product and Service Introduction of China Isotope & Radiation

    • Table Company Profile and Development Status of Progenics Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals

    • Table Product and Service Introduction of Progenics Pharmaceuticals

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Dongcheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng

    • Figure Sales and Growth Rate Analysis of Dongcheng

    • Figure Revenue and Market Share Analysis of Dongcheng

    • Table Product and Service Introduction of Dongcheng

    • Table Company Profile and Development Status of Spectrum Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spectrum Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Spectrum Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Spectrum Pharmaceuticals

    • Table Product and Service Introduction of Spectrum Pharmaceuticals


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.